Health coverage can significantly influence a patient’s access to treatment. How aligned are coverage decisions made by health plans to available evidence? How aligned should they be? Recent research from the National Pharmaceutical Council and the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center, published in Health Affairs, sheds light on this question.
Register
Join the webinar to learn:
- How health plans vary in the quantity, breadth and types of evidence they use to inform coverage decisions
- How coverage for specialty medicines by U.S. commercial health plans varies and the challenges these variations present
- The current state of formulary development practices and priority considerations for stakeholders working to update formulary practices
